Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer
- 1 April 2016
- journal article
- Published by Elsevier in Biomaterials
- Vol. 84, 42-53
Abstract
No abstract availableKeywords
Funding Information
- UNC Lineberger Comprehensive Cancer Center's University Cancer Research Fund (KL2TR001109)
- UNC Translational and Clinical Sciences Institute (UL1TR001111)
This publication has 45 references indexed in Scilit:
- Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative DiseasesPLOS ONE, 2013
- Permeability of Three-Dimensional Fibrin Constructs Corresponds to Fibrinogen and Thrombin ConcentrationsBioResearch Open Access, 2012
- Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomasNature Neuroscience, 2011
- Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenograftsCancer Letters, 2011
- A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant GliomaMolecular Pharmaceutics, 2011
- Fibrin glue as a drug delivery systemJournal of Controlled Release, 2010
- A Novel Molecule Integrating Therapeutic and Diagnostic Activities Reveals Multiple Aspects of Stem Cell-based TherapyStem Cells, 2010
- The hard life of soft cellsCell Motility, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapyProceedings of the National Academy of Sciences, 2009